DIGITS: Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care

Sponsor
Kaiser Permanente (Other)
Overall Status
Recruiting
CT.gov ID
NCT05160233
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
13,000
1
4
31
419.6

Study Details

Study Description

Brief Summary

The DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders in primary care. The DIGITS Trial is a partnership between Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, and Kaiser Permanente Washington, a healthcare delivery system in Washington State.

In this study, the FDA-authorized reSET and reSET-O digital therapeutics will be implemented in Kaiser Permanente Washington primary care clinics. The study will evaluate the extent to which two implementation strategy interventions, health coaching and practice coaching, improve the implementation. Primary care clinics are randomized to receive these implementation strategy interventions. Each clinic will have a 12-month active implementation period beginning on its date of randomization. To study the continued use of reSET and reSET-O after the active implementation period is completed, a sustainment period of up 12 months will follow the active implementation period.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Standard implementation
  • Behavioral: Health Coaching
  • Behavioral: Practice Facilitation
N/A

Detailed Description

Specific Aims of the DIGITS Trial are to:
  1. Estimate the effect of practice facilitation and health coaching implementation strategies in increasing the reach and fidelity of a digital therapeutic for substance use disorders in primary care clinics.

  2. Compare the population-level cost-effectiveness of each implementation strategy in increasing reach, fidelity, and abstinence.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
13000 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
Cluster-randomized trial with 2x2 factorial randomization of two experimental strategies resulting in four arms: 2x2 factorial design to four approaches: (1) "standard implementation"; (2) "standard implementation plus practice facilitation"; (3) "standard implementation plus health coach"; and (4) "standard implementation plus both.Cluster-randomized trial with 2x2 factorial randomization of two experimental strategies resulting in four arms: 2x2 factorial design to four approaches: (1) "standard implementation"; (2) "standard implementation plus practice facilitation"; (3) "standard implementation plus health coach"; and (4) "standard implementation plus both.
Masking:
Single (Outcomes Assessor)
Masking Description:
All outcomes are derived from secondary administrative data.
Primary Purpose:
Health Services Research
Official Title:
Digital Treatments for Opioids and Other Substance Use Disorders (DIGITS) in Primary Care: A Hybrid Type-III Implementation Trial
Actual Study Start Date :
Dec 9, 2021
Anticipated Primary Completion Date :
Mar 9, 2023
Anticipated Study Completion Date :
Jul 9, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard Implementation

All primary care clinics will implement reSET and reSET-O using standard implementation approach.

Behavioral: Standard implementation
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.

Experimental: Standard Implementation Plus Health Coaching

The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O.

Behavioral: Standard implementation
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.

Behavioral: Health Coaching
The clinic is provided access to a health coach who conducts outreach with patients. The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.

Experimental: Standard Implementation Plus Practice Facilitation

The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and a practice facilitator will provide the clinic with support for implementation.

Behavioral: Standard implementation
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.

Behavioral: Practice Facilitation
A trained facilitator provides support for implementation by delivering the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.

Experimental: Standard Implementation Plus Health Coaching and Practice Facilitation

The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O. Additionally, a practice facilitator will provide the clinic with support for implementation.

Behavioral: Standard implementation
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.

Behavioral: Health Coaching
The clinic is provided access to a health coach who conducts outreach with patients. The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.

Behavioral: Practice Facilitation
A trained facilitator provides support for implementation by delivering the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.

Outcome Measures

Primary Outcome Measures

  1. Reach of the digital therapeutic to patients in the primary care clinic [12 months]

    The proportion of patients who initiate the digital therapeutic, defined by instances in which patients open the app, enter the prescription code, and use a treatment module.

  2. Fidelity of patients' use of the digital therapeutic to clinical recommendations [15 months]

    Mean number of weeks during patients' 12-week prescription in which patients use 4 app modules/week and have visited a clinician in the past 30 days

Secondary Outcome Measures

  1. Engagement [15 months]

    Mean number of months in which patients make ≥1 visit for substance use disorder

  2. Economic costs [12 months]

    Costs from the perspective of a health system and payer including implementation, direct intervention, operating, and other indirect health care costs. This measure will be used to calculate the population-level cost effectiveness of increasing reach, fidelity, and engagement.

Other Outcome Measures

  1. Reach-2 [12 months]

    The proportion of patients prescribed reSET or reSET-O

  2. Fidelity-2 [15 months]

    Mean number of weeks in which patients use at least 1 module/week

  3. Sustainment [12 months]

    The proportion of patients who are reached during the sustainment period

  4. Substance use [Up to 18 months from the patients index visit date]

    The proportion of patients who are reached and reduce their substance use

  5. Abstinence [Up to 18 months from the patients index visit date]

    The proportion of patients who are reached and are abstinent from substances

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Patient Inclusion Criteria:
  • Had a primary care visit in a participating clinic during the active implementation period or sustainment period

  • Screened positive for substance use on the day of the visit or in the prior year

  • Adult aged 18 years or older at time of visit

Clinic Inclusion Criteria:
  • At least 1 clinician trained in the use of reSET/reSET-O
Patient Exclusion Criteria:
  • Patients who have requested through their health system to opt out of research
Clinic Exclusion Criteria:
  • Previously participated in a pilot implementation of reSET/reSET-O

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kaiser Permanente Washington Seattle Washington United States 98101

Sponsors and Collaborators

  • Kaiser Permanente
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Joseph E Glass, PhD, MSW, Kaiser Permanente

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT05160233
Other Study ID Numbers:
  • 1794767
  • R01DA047954
First Posted:
Dec 16, 2021
Last Update Posted:
Jan 18, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kaiser Permanente
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2022